drugset / Trial / NCT03069339

Carvedilol, Endoscopic Variceal Ligation or Combination of Both for Prevention of First Variceal Bleed in Child's B & C Cirrhosis

NCT03069339 ↗

RandomizedParallel-groupOpen-labelTreatment

Summary

Study Design: Open labeled randomized controlled trial. The study will be conducted on patients attending outpatient or admitted to admitted to Department of Hepatology from January 2017 to December 2018 at ILBS, New Delhi

Timeline

Start
2017-03-15
Primary completion
2020-11-30
Completion
2020-11-30

Outcome

Met primary endpoint

paper significantly reduced the incidence of first variceal bleed by 62.9% as compared with group B (HR 0.37, 95% CI 0.192 to 0.716, p<0.003) PMID 39067870 ↗

paper by 69.3% as compared with group A (HR 0.31, 95% CI 0.163 to 0.578, <0.001) PMID 39067870 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Carvedilol Other / unclassified 12.5 mg —

Indications